Literature DB >> 2711931

Effects of topically applied glucocorticosteroids on patch test responses and recruitment of inflammatory cells in allergic contact dermatitis.

E P Prens1, K Benne, A M Geursen-Reitsma, G van Dijk, R Benner, T van Joost.   

Abstract

The effects of repeated topical application of a strong glucocorticosteroid (GCS) on patch test responses and the inflammatory infiltrate were studied in twenty nickel allergic patients. Patch test responses were strongly inhibited in 18 out of 20 patients. Immunohistochemical analysis revealed marked reductions in CD1+(T6+) Langerhans cells, activated inflammatory T cells and of mast cells in the skin. It is concluded that GCS suppress contact allergic responses by reduction, or functional inhibition of antigen presenting cells. The reduced number of mast cells release less vasoactive mediators, inhibiting recruitment of inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2711931     DOI: 10.1007/BF02126583

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  4 in total

1.  Quantification of patch test reactions by transcutaneous PO2 measurement.

Authors:  E P Prens; T van Joost; J Steketee
Journal:  Contact Dermatitis       Date:  1987-03       Impact factor: 6.600

2.  Effect of glucocorticosteroids on epidermal cell-induced immune responses.

Authors:  W Aberer; L Stingl; S Pogantsch; G Stingl
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

3.  Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.

Authors:  J Ashworth; J Booker; S M Breathnach
Journal:  Br J Dermatol       Date:  1988-04       Impact factor: 9.302

4.  Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells.

Authors:  S Sullivan; P R Bergstresser; R E Tigelaar; J W Streilein
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.